MEDIPAL HOLDINGS Corporation

As of March 31, 2026, Medipal Holdings Corp. carries a market capitalization of 3.78B, placing it among publicly traded companies globally. Its enterprise value stands at 2.86B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Medipal Holdings Corp.'s next confirmed earnings release is scheduled for November 5, 2026.

As of March 31, 2026, Medipal Holdings Corp. has 204.70M shares outstanding.

These figures are as of March 31, 2026.

As of March 31, 2026, Medipal Holdings Corp. maintains a current ratio of 1.28, meaning it holds 1.3x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended March 31, 2026.

As of the close on September 18, 2026, Medipal Holdings Corp.'s stock has gained approximately 17.36% over the past 52 weeks.

These figures are as of March 31, 2026. Total book value stands at 4.11B, with working capital of 1.91B providing operational flexibility.

Medipal Holdings Corp.'s most recent stock split took place on March 26, 1996 with a 10:11 split ratio.